Optical Coherence Tomography Angiography for Diagnosis of Choroidal Neovascularization in Chronic Central Serous Chorioretinopathy after Photodynamic Therapy

被引:0
作者
Jian-Sheng Wu
San-Ni Chen
机构
[1] Changhua Christian Hospital,Department of Ophthalmology
[2] Chung Shan Medical University,Department of Optometry
[3] Da-Yeh University,Department of Optometry
[4] Chung Shan Medical University,School of Medicine
来源
Scientific Reports | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The authors evaluated the proportion of choroidal neovascularization (CNV) detected by spectral-domain optical coherence tomography angiography (OCTA) in eyes with chronic central serous chorioretinopathy (CSC) (more than 3 months) with previous treatment via half-dose photodynamic therapy (PDT). All patients were followed up with at least twelve months. Macular angiograms were obtained using spectral-domain OCT (SD-OCT, RTVue XR; Optovue). CNV was defined as flow in the outer retinal slab between the outer plexiform layer and Bruch’s membrane. Clinical characteristics were compared between CNV and non-CNV groups. Seventy eyes of 61 patients (51 male and 10 female) were included. The average age was 46.2 years old. The average duration of symptom was 32.9 months. All patients were treated with half-dose PDT initially. Eleven eyes (15.7%) received more than one session of PDT. CNV was diagnosed in 32 of 70 eyes (45.7%) based on OCTA. Only 6 of the 32 eyes (18.8%) needed intravitreal anti- vascular endothelial growth factor (VEGF) therapy for the exudative activity of CNV. Older age (p = 0.059), larger PDT spot size (p = 0.024), and thinner subfoveal choroidal thickness (p = 0.008) were noted in CNV group. The authors conclude that OCTA reveals high rates of CNV associated with chronic CSC after PDT. Patients in the CNV group had older age, larger PDT spot size, and thinner subfoveal choroidal thickness. OCTA may be considered as a first step in identifying CNV in chronic CSC following PDT.
引用
收藏
相关论文
共 92 条
[1]  
Imamura Y(2011)Fundus autofluorescence and visual acuity in central serous chorioretinopathy Ophthalmology 118 700-705
[2]  
Fujiwara T(2008)Central serous chorioretinopathy Acta. Ophthalmol. 86 126-145
[3]  
Spaide RF(2003)Photodynamic therapy for chronic central serous chorioretinopathy Retina 23 752-763
[4]  
Wang M(2009)Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy Jpn. J. Ophthalmol. 53 52-56
[5]  
Munch IC(2014)Photodynamic therapy for central serous chorioretinopathy Eye (Lond) 28 944-957
[6]  
Hasler PW(2002)Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy Retina 22 19-24
[7]  
Prünte C(2007)Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin Am. J. Ophthalmol. 143 977-983
[8]  
Larsen M(1996)Central serous chorioretinopathy in younger and older adults Ophthalmology 103 2070-2079
[9]  
Piccolino FC(2014)Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration Ophthalmology 121 1435-1444
[10]  
Eandi CM(2015)Spectral-domain optical coherence tomography angiography of choroidal neovascularization Ophthalmology 122 1228-1238